Connection
Joel Marrs to Hypolipidemic Agents
This is a "connection" page, showing publications Joel Marrs has written about Hypolipidemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.926 |
|
|
|
-
Marrs JC, Saseen JJ. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy. 2010 Aug; 30(8):823-9.
Score: 0.329
-
Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9.
Score: 0.282
-
Patel SB, Wyne KL, Afreen S, Belalcazar LM, Bird MD, Coles S, Marrs JC, Peng CC, Pulipati VP, Sultan S, Zilbermint M. American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia. Endocr Pract. 2025 Feb; 31(2):236-262.
Score: 0.225
-
Marrs JC. Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease. Am J Manag Care. 2011 Dec; 17 Suppl 15:S403-11.
Score: 0.090